Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,703 | 65,741 | 133,606 | 104,820 | 120,179 |
| Marketable Securities | 220,310 | 280,965 | 251,840 | 263,363 | 301,083 |
| Receivables | 97,730 | 62,551 | 37,401 | 29,749 | 59,442 |
| Inventories | 60,747 | 57,697 | 48,271 | 41,452 | 29,359 |
| TOTAL | $554,764 | $498,895 | $500,358 | $467,971 | $543,436 |
| Non-Current Assets | |||||
| PPE Net | 10,593 | 10,252 | 11,169 | 11,752 | 10,855 |
| Other Non-Current Assets | 14,567 | 14,882 | 15,470 | 12,630 | 11,583 |
| TOTAL | $25,160 | $25,134 | $26,639 | $24,382 | $22,438 |
| Total Assets | $579,924 | $524,029 | $526,997 | $492,353 | $565,874 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 397,228 | N/A | N/A | 2,859 | 19,542 |
| Accounts payable and accrued liabilities | 1,928 | 433 | 4,067 | 8,320 | 6,434 |
| Accrued Expenses | 20,483 | 25,795 | 21,258 | 26,811 | 55,649 |
| TOTAL | $421,385 | $26,976 | $26,073 | $42,002 | $85,637 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 393,631 | 390,079 | 386,571 | 383,045 |
| Deferred Revenues | 1,746 | 748 | 748 | 4,012 | 4,012 |
| Other Non-Current Liabilities | 3,466 | 3,793 | 4,627 | 5,097 | 4,180 |
| TOTAL | $7,492 | $398,065 | $395,347 | $392,309 | $388,472 |
| Total Liabilities | $428,877 | $425,041 | $421,420 | $434,311 | $474,109 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 135,276 | 135,183 | 137,027 | 135,815 | 138,226 |
| Common Shares | 135 | 135 | 137 | 135 | 137 |
| Retained earnings | -474,593 | -547,757 | -583,964 | -609,781 | -603,678 |
| Other shareholders' equity | 22 | 426 | 1,086 | 11 | 240 |
| TOTAL | $151,047 | $98,988 | $105,577 | $58,042 | $91,765 |
| Total Liabilities And Equity | $579,924 | $524,029 | $526,997 | $492,353 | $565,874 |